SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Profound Medical Corp. (PROF) News

Track canonical SquawkNews coverage tagged to PROF, Profound Medical Corp.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 7 indexed stories across 7 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol PROF Asset equity Sector Markets 90 days 7 Last 5.87 Updated Sep 17, 2026, 02:24 PM UTC Open live news feed
M Profile Software reports €4.9 million net profit, up 63% YoY Profile Systems & Software SA reported first-half net profit of €4.9 million, up 63% year-on-year. EARNINGS | Sep 17, 2026, 02:24 PM UTC L PROF - Profound Medical to Participate in Lake Street’s 10th Annual Best Ideas Growth Conference PROF - Profound Medical to Participate in Lake Street’s 10th Annual Best Ideas Growth Conference EQUITY | Sep 03, 2026, 12:15 PM UTC L Profound Medical appoints Richard Fabian as President Profound Medical further strengthens its executive leadership team with the appointment of Richard Fabian as President. EQUITY | Sep 01, 2026, 12:01 PM UTC M Profound introduces new real-time interventional MRI software Profound (PROF) introduces new real-time interventional MRI software, with the company stating it is intended to enable full “TULSA Days.” EQUITY | Aug 17, 2026, 12:31 PM UTC L Profound Medical announces management change Profound Medical (PROF) announces a management change, with no further details, timing, or rationale provided in the alert. REGULATION | Aug 14, 2026, 08:30 PM UTC L PROF - Profound Medical Launches ‘Let's Huddle’, a Global Community Supporting Men Throughout Their Prostate Care Journey - Click For Releas PROF - Profound Medical Launches ‘Let's Huddle’, a Global Community Supporting Men Throughout Their Prostate Care Journey EQUITY | Aug 13, 2026, 08:16 PM UTC L Profound Medical Affirms FY2026 Sales Guidance of $25.000M vs $26.858M Est Profound Medical (NASDAQ: PROF ) affirms FY2026 sales outlook from $25.000 million to $25.000 million vs $26.858 million estimate. EARNINGS | Aug 06, 2026, 08:50 PM UTC